Answers are grounded in this paper and cite their sources.
Plasmablastic lymphoma (PBL) is very rare aggressive variant of B-cell lymphoma, characterized by plasmablastic morphology associated with immunodeficiency. It has strong and common association with HIV and EBV positive individuals. Subsequently, the spectrum of the disease has widened to include extraoral and nodal sites, as well as cases without mucosal involvement, EBV infection, or HIV association, leading to atypical presentations. These variations pose significant diagnostic challenges, particularly in differentiating PBL from other hematolymphoid malignancies with plasmablastic features, such as ALK1-positive large B-cell lymphoma, HHV8-positive diffuse large B-cell lymphoma not otherwise specified (NOS), and the solid variant of primary effusion lymphoma, as well as from plasmablastic plasma cell myeloma. Additionally, poorly differentiated carcinoma and amelanotic melanoma should be excluded during differential diagnosis. This article presents a rare case of PBL involving the maxillary gingiva and discusses its histogenesis, key differential diagnoses, and the critical role of clinical evaluation, histopathological features, and immunohistochemical profiling in establishing an accurate diagnosis.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: